D
David W. Wright
Researcher at Emory University
Publications - 209
Citations - 15372
David W. Wright is an academic researcher from Emory University. The author has contributed to research in topics: Traumatic brain injury & Poison control. The author has an hindex of 55, co-authored 196 publications receiving 12553 citations. Previous affiliations of David W. Wright include University of California, San Francisco & Grady Memorial Hospital.
Papers
More filters
Journal ArticleDOI
Guidelines for the Management of Severe Traumatic Brain Injury, Fourth Edition
Nancy Carney,Annette M Totten,Cindy O’Reilly,Jamie S. Ullman,Gregory W.J. Hawryluk,Michael J. Bell,Susan L. Bratton,Randall M. Chesnut,Odette A. Harris,Niranjan Kissoon,Andres M. Rubiano,Lori Shutter,Robert C. Tasker,Monica S. Vavilala,Jack Wilberger,David W. Wright,Jamshid Ghajar +16 more
TL;DR: The scope and purpose of this work is to synthesize the available evidence and to translate it into recommendations, so that these recommendations be used by others to develop treatment protocols, which necessarily need to incorporate consensus and clinical judgment in areas where current evidence is lacking or insufficient.
Journal ArticleDOI
Position Statement: Definition of Traumatic Brain Injury
TL;DR: Criteria for considering or establishing a diagnosis of TBI is discussed, with a particular focus on how a diagnosis can be made when patients present late after injury and how mild TBI may be differentiated from non-TBI causes with similar symptoms.
Journal ArticleDOI
ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury.
David W. Wright,Arthur L. Kellermann,Vicki S. Hertzberg,Pamela L. Clark,Michael Frankel,Felicia C. Goldstein,Jeffrey P. Salomone,L. Leon Dent,Odette A. Harris,Douglas S. Ander,Douglas W. Lowery,Manish M. Patel,Donald D. Denson,Angelita B. Gordon,Marlena M. Wald,Sanjay Gupta,Stuart W. Hoffman,Donald G. Stein +17 more
TL;DR: Moderate traumatic brain injury survivors who received progesterone were more likely to have a moderate to good outcome than those randomized to placebo and showed possible signs of benefit.
Journal ArticleDOI
Very Early Administration of Progesterone for Acute Traumatic Brain Injury
David W. Wright,Sharon D. Yeatts,Robert Silbergleit,Yuko Y. Palesch,Vicki S. Hertzberg,Michael Frankel,Felicia C. Goldstein,Angela F. Caveney,Harriet Howlett-Smith,Erin M Bengelink,Geoffrey T. Manley,Lisa H. Merck,L. Scott Janis,William G. Barsan +13 more
TL;DR: This clinical trial did not show a benefit of progesterone over placebo in the improvement of outcomes in patients with acute TBI, and there were no significant differences in the other prespecified safety outcomes.
Journal ArticleDOI
Characteristics and Clinical Outcomes of Adult Patients Hospitalized with COVID-19 - Georgia, March 2020.
Jeremy A W Gold,Karen K. Wong,Christine M Szablewski,Priti R. Patel,John Rossow,Juliana Almeida da Silva,Pavithra Natarajan,Sapna Bamrah Morris,Robyn Neblett Fanfair,Jessica Rogers-Brown,Beau B. Bruce,Sean D Browning,Sean D Browning,Alfonso C Hernandez-Romieu,Nathan W. Furukawa,Mohleen Kang,Mary Evans,Nadine Oosmanally,Melissa Tobin-D'Angelo,Cherie Drenzek,David J. Murphy,Julie Hollberg,James M. Blum,Robert Jansen,David W. Wright,David W. Wright,William Sewell,Jack Owens,Benjamin Lefkove,Frank W. Brown,Deron C. Burton,Timothy M. Uyeki,Stephanie R. Bialek,Brendan R Jackson +33 more
TL;DR: Medical record-abstracted data for hospitalized adult patients with laboratory-confirmed COVID-19 who were admitted during March 2020 revealed an overrepresentation of black patients within this hospitalized cohort, which is important for public health officials to ensure that prevention activities prioritize communities and racial/ethnic groups most affected by CO VID-19.